Valspodar

DB11869InvestigationalSmall molecule

Valspodar has been used in trials studying the treatment of Cancer, Sarcoma, Leukemia, Lymphoma, and Breast Cancer, among others.

Mechanism: Pharmacologically active on ATP-dependent translocase ABCB1
Curator reviewed
Formula / weight: C₆₃H₁₁₁N₁₁O₁₂ · 1214.646 g/mol (avg)
Also known as: AMDRAY
Code names: PSC 833

Resolves to

Compound

UNIIQ7ZP55KF3XCAS121584-18-7ChEMBLCHEMBL1086218ChEBI8985PubChem5281884KEGGC11213

Structure

InChIKeyYJDYDFNKCBANTM-QCWCSKBGSA-NSMILES

C\C=C\C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C

Targets

P08183ABCB1P00742F10

Transporters

Q9Y6L6SLCO1B1Q9NPD5SLCO1B3P08183ABCB1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3TransportersSubstrate / inhibitor direction, not just membership

Listed above

301Drug interactionsStructured to mechanism, not free text

11Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Valspodar, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account